'SCOTUS Ruling on Braidwood EXACT-ly What Was Needed' for Exact Sciences (EXAS) - Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Puneet Souda reiterated an Outperform rating and $90.00 price target on Exact Sciences (NASDAQ: EXAS), saying the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
